title: A brief review of the estimated economic burden of sexually transmitted diseases in the United States: inflation-adjusted updates of previously published cost studies.
abstract: We conducted a literature review of studies of the economic burden of sexually transmitted diseases in the United States. The annual direct medical cost of sexually transmitted diseases (including human immunodeficiency virus) has been estimated to be $16.9 billion (range: $13.9-$23.0 billion) in 2010 US dollars.
authors.affiliation: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. hbc7@cdc.gov
authors.forename: Harrell W
authors.initials: HW
authors.lastname: Chesson
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Gift
authors.forename: Kwame
authors.initials: K
authors.lastname: Owusu-Edusei
authors.forename: Guoyu
authors.initials: G
authors.lastname: Tao
authors.forename: Ana P
authors.initials: AP
authors.lastname: Johnson
authors.forename: Charlotte K
authors.initials: CK
authors.lastname: Kent
mesh_terms: D017281:Cost of Illness; D006801:Humans; D007250:Inflation, Economic; D012749:Sexually Transmitted Diseases / Q000191:economics*; D014481:United States